Merck Will Share License For COVID-19 Pill With Nonprofit To Facilitate Global Access

The Washington Post (10/27, Taylor, Parker) reports, “U.S. pharmaceutical giant Merck has agreed to share its license for its experimental covid-19 drug, molnupiravir, with a nonprofit organization so that it can be manufactured widely around the world in...